Fate Therapeutics (FATE)
(Delayed Data from NSDQ)
$5.41 USD
-0.03 (-0.55%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $5.41 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.47 |
EPS Last Quarter | -0.47 |
Last EPS Surprise | 0.00% |
ABR | 2.48 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.90 |
Next Year | -1.42 |
EPS (TTM) | -1.92 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.47M | 0.80M | 4.34M | 3.60M |
# of Estimates | 6 | 6 | 7 | 2 |
High Estimate | 5.00M | 1.00M | 8.90M | 4.00M |
Low Estimate | 0.50M | 0.50M | 1.93M | 3.20M |
Year ago Sales | 0.93M | 1.94M | 63.53M | 4.34M |
Year over Year Growth Est. | 57.63% | -58.76% | -93.17% | -17.05% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.47 | -0.48 | -1.90 | -1.42 |
# of Estimates | 9 | 7 | 11 | 9 |
Most Recent Consensus | -0.40 | -0.44 | -2.19 | -0.09 |
High Estimate | -0.40 | -0.43 | -1.30 | 1.93 |
Low Estimate | -0.54 | -0.55 | -2.62 | -2.46 |
Year ago EPS | -0.54 | -0.46 | -1.64 | -1.90 |
Year over Year Growth Est. | 12.96% | -4.35% | -15.85% | 25.12% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.47 | -0.48 | -1.90 | -1.42 |
7 Days Ago | -0.47 | -0.48 | -1.90 | -1.42 |
30 Days Ago | -0.47 | -0.48 | -1.90 | -1.42 |
60 Days Ago | -0.47 | -0.48 | -1.90 | -1.42 |
90 Days Ago | -0.47 | -0.47 | -1.94 | -1.84 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.47 | -0.48 | -1.90 | -1.42 |
Zacks Consensus Estimate | -0.47 | -0.48 | -1.90 | -1.42 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.47 | -0.45 | -0.46 | -0.54 | NA |
Estimate | -0.47 | -0.57 | -0.59 | -0.58 | NA |
Difference | 0.00 | 0.12 | 0.13 | 0.04 | 0.07 |
Surprise | 0.00% | 21.05% | 22.03% | 6.90% | 12.50% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more